More from the Author

• Course Overview Note | 2013 (Revised from original 2013 version)

  The Entrepreneurial Manager: Course Overview, 2013 Winter Term

  Richard G. Hamermesh, Richard G. Hamermesh and Thomas Eisenmann

  Course overview of The Entrepreneurial Manager.

  Keywords: Entrepreneurship; Management; Business Education;

  Citation:

  Hamermesh, Richard G., and Thomas Eisenmann. "The Entrepreneurial Manager: Course Overview, 2013 Winter Term." Harvard Business School Course Overview Note 813-155, January 2013. (Revised from original January 2013 version.)

  CiteView DetailsPurchase

  Related

• Case | HBS Case Collection | 2013 (Revised from original 2012 version)

  Companion Diagnostics: Uncertainties for Approval and Reimbursement

  Richard G. Hamermesh, Norman C. Selby and Phillip Andrews

  The FDA approvals of novel therapeutics were seen as signs in the personalized medicine community of real progress in the growth of personalized medicine. The FDA's approval of such drugs, along with companion diagnostics, suggested a shift in thinking and regulatory practices at the agency. Beyond the regulatory questions, many considered the reimbursement system archaic, dispersed, unpredictable, and unnecessarily time consuming. Many questioned whether the traditional models of reimbursement were relevant in the era of personalized medicine, and who should be covering the cost of tests needed to identify the sometimes small number of patients who could benefit from expensive targeted drugs. This case focuses on the array of possibilities and the ambiguity surrounding these regulatory and reimbursement issues.

  Keywords: models of reimbursement; personalized medicine; regulation; healthcare reform; Health Care and Treatment; Health Industry; United States;

  Citation:

  Hamermesh, Richard G., Norman C. Selby, and Phillip Andrews. "Companion Diagnostics: Uncertainties for Approval and Reimbursement." Harvard Business School Case 813-037, January 2013. (Revised from original November 2012 version.)

  CiteView DetailsPurchase

  Related

• Case | HBS Case Collection | 2012 (Revised from original 2011 version)

  eHealthpoint: Healthcare for Rural India

  Richard G. Hamermesh, Mona Sinha and Elizabeth Vrolyk

  Healthpoint Services sought to address rural India's shortage of quality and affordable healthcare with a multi-service platform that comprised telemedical health clinics called eHealthpoints, clean drinking water, a diagnostic lab, and a pharmacy. Could they convince rural Indians to leapfrog from local healers to telemedicine? And could they convince Investors that their capital Intensive, bundled offering was a high-growth, self-sustaining venture? Healthpoint Services grappled with multiple challenges: changing mind-sets of patients and investors, generating traffic at their eHealthpoints, expanding their product portfolio, and growing within and outside India.

  Keywords: Health Care and Treatment; Health Industry; India;

  Citation:

  Hamermesh, Richard G., Mona Sinha, and Elizabeth Vrolyk. "eHealthpoint: Healthcare for Rural India." Harvard Business School Case 812-020, December 2012. (Revised from original October 2011 version.)

  CiteView DetailsPurchase

  Related